About Eos BioInnovation
Eos BioInnovation is a Healthcare company based in Cambridge (United States). Eos BioInnovation is focused on incubating regenerative medicine companies. It operates on a Professional Services and HealthTech model. Eos BioInnovation offers products and services including Regenerative Medicine Incubation, Cell and Gene Therapies, and Biomaterials Engineering. Its focus areas include Biotechnology and Regenerative Medicine.
Company details
Eos BioInnovation is engaged in incubating, launching, and building early-stage companies in regenerative medicine, emerging from leading academic labs and research institutions. The focus is placed on therapies and technologies that repair, replace, or regenerate organs, tissues, cells, and genes to address root causes of diseases. Strategic investments and affiliations with institutions like the Harvard Stem Cell Institute are utilized to nurture innovations. A balanced portfolio spanning cell and gene therapies, biomaterials, and enabling technologies is maintained. The network of advisors and industry connections is leveraged to provide expertise to portfolio companies, contributing to the healthcare ecosystem.
- Headquarters Cambridge, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website eosbioinnovation.com
Products & Services of Eos BioInnovation
Eos BioInnovation offers a comprehensive portfolio of products and services, including Regenerative Medicine Incubation, Cell and Gene Therapies, and Biomaterials Engineering.
Early-stage companies in regenerative medicine are incubated strategically.
Innovative therapies for regenerative medicine are developed extensively.
Engineered biomaterials for medical applications are created innovatively.
Top companies in Cell Therapy
3 companies that operate in the same segment as Eos BioInnovation (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eos BioInnovation
Eos BioInnovation is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Eos BioInnovation is engaged in incubating, launching, and building early-stage companies in regenerative medicine, emerging from leading academic labs and research institutions. The focus is placed on therapies and technologies that repair, replace, or regenerate organs, tissues, cells, and genes to address root causes of diseases. Strategic investments and affiliations with institutions like the Harvard Stem Cell Institute are utilized to nurture innovations. A balanced portfolio spanning cell and gene therapies, biomaterials, and enabling technologies is maintained. The network of advisors and industry connections is leveraged to provide expertise to portfolio companies, contributing to the healthcare ecosystem.
Eos BioInnovation offers Regenerative Medicine Incubation, Cell and Gene Therapies, and Biomaterials Engineering.